On Thursday, Shares of Marriott International Inc (NASDAQ:MAR), gained 4.09% to $76.87.
The Ritz-Carlton Hotel Company, L.L.C. is a wholly-owned partner of Marriott International, Inc. (MAR).
Throughout its 32 year history, The Ritz-Carlton Hotel Company, L.L.C. has always been known as a leader in luxury meetings for both corporate and incentive programs hosted in the iconic brand’s hotels and resorts worldwide. “Tailoring custom experiences for attendees has always been a preceding for us, and recently the localization of those experiences has become extremely popular,” said John Harper, Vice President, Sales for The Ritz-Carlton. “Our meeting planners host events with specific aims in mind, whether it be retaining talent or inspiring customers. We partner with our customers to assist them create stronger relationships with their attendees,” Harper continued. Once again, The Ritz-Carlton was voted #1 in guest satisfaction for 2015 by J.D. Power and Associates.
Marriott International, Inc. operates, franchises, and licenses hotels and timeshare properties worldwide. It operates through three segments: North American Full-Service, North American Limited-Service, and International.
Shares of McKesson Corporation (NYSE:MCK), declined -2.78% to $181.44, during its last trading session.
McKesson Corporation, declared that John Hammergren, chairman and chief executive officer, will present at the 24th Annual Credit Suisse Healthcare Conference in Scottsdale at 8:00 a.m. MT on Tuesday, November 10, 2015.
McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions.
Finally, Shares of Cempra Inc (NASDAQ:CEMP), ended its last trade with -7.51% loss, and closed at $15.76.
Cempra, stated financial results for the quarter ended September 30, 2015 and offered an update on recent corporate developments. The company will host a webcast and conference call at 8:00 a.m. EDT.
Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet medical needs in the treatment of bacterial infectious diseases in North America. Its lead product candidates comprise solithromycin (CEM-101), which is in Phase III clinical trials for the treatment of community attained bacterial pneumonia, in addition to for uncomplicated bacterial urethritis; and Taksta (CEM-102), an antibiotic that has accomplished Phase II clinical trials for refractory bone and joint infections.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.